These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29911403)

  • 1. How 4 Companies Became One: Co-development Under an Outsourced Model With Focus on Phase 3 Analysis and Reporting Deliverables.
    Huyck S; Golm G; Ghani S; Mancuso J; Irvin T
    Ther Innov Regul Sci; 2019 May; 53(3):301-306. PubMed ID: 29911403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Hennig M; Hundt F; Busta S; Mikus S; Sanden PH; Sörgel A; Ruppert T
    Ger Med Sci; 2017; 15():Doc02. PubMed ID: 28163667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ertugliflozin: First Global Approval.
    Markham A
    Drugs; 2018 Mar; 78(4):513-519. PubMed ID: 29476348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials integrity: a CRO perspective.
    Beach JE
    Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.
    Sariola S; Ravindran D; Kumar A; Jeffery R
    Soc Sci Med; 2015 Apr; 131():239-46. PubMed ID: 25476783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of high-quality marketing applications: strategies for biotechnology companies working with contract research organizations.
    Hecker SJ; Preston C; Foote M
    Biotechnol Annu Rev; 2003; 9():269-77. PubMed ID: 14650931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taking the pulse of strategic outsourcing relationships.
    Getz KA; Lamberti MJ; Kaitin KI
    Clin Ther; 2014 Oct; 36(10):1349-55. PubMed ID: 25444564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus.
    Sahasrabudhe V; Terra SG; Hickman A; Saur D; Shi H; O'Gorman M; Zhou Z; Cutler DL
    J Clin Pharmacol; 2017 Nov; 57(11):1432-1443. PubMed ID: 28703316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ertugliflozin for the treatment of type 2 diabetes.
    Sharma R; Razdan K; Kuhad A; Kuhad A
    Drugs Today (Barc); 2019 Mar; 55(3):167-175. PubMed ID: 30938372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug development process and COVID-19 pandemic: Flourishing era of outsourcing.
    Wasan H; Singh D; Reeta KH; Gupta P; Gupta YK
    Indian J Pharmacol; 2022; 54(5):364-372. PubMed ID: 36537406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-Based Monitoring: Key Conditions in Collaboration Between Contract Research Organization and Sponsor.
    Wolfs M; Bambic A; Lange BS; Galante K; Plaza RS; O'Conallain C; Racaro G; Giblin M; Djali S
    Ther Innov Regul Sci; 2019 Jul; 53(4):512-518. PubMed ID: 30157695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ertugliflozin as a monotherapy for the treatment of type 2 diabetes.
    Hu J; Deng A; Zhao Y
    Expert Opin Pharmacother; 2018 Nov; 19(16):1841-1847. PubMed ID: 30223693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of Outsourcing Strategy and IT Technology in Clinical Trials.
    Stamenovic M; Dobraca A
    Acta Inform Med; 2017 Sep; 25(3):203-207. PubMed ID: 29114116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating internal and external bioanalytical support to deliver a diversified pharmaceutical portfolio.
    Summerfield SG; Evans C; Spooner N; Dunn JA; Szapacs ME; Yang E
    Bioanalysis; 2014 May; 6(10):1311-9. PubMed ID: 24958115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials in India.
    Maiti R; M R
    Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharma Collaboration for Transparent Medical Information (phactMI™) Benchmark Study: Results of Organizational Structure and Resourcing of Medical Information Services in Support of Building Departmental Strategies.
    Marasigan K; Doshi S; Fung S
    Ther Innov Regul Sci; 2020 Nov; 54(6):1269-1274. PubMed ID: 33123969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NN-414. Novo Nordisk.
    Choi JK
    Curr Opin Investig Drugs; 2003 Apr; 4(4):455-8. PubMed ID: 12808887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.